Hematopoietic Stem Cell TransplantationBone Marrow TransplantationTransplantation, HomologousHematopoietic Stem CellsGraft vs Host DiseaseTransplantation, AutologousStem Cell TransplantationTransplantation ConditioningBone MarrowBone Marrow CellsHematologic NeoplasmsTransplantation ChimeraWhole-Body IrradiationPeripheral Blood Stem Cell TransplantationTissue DonorsStem CellsGraft SurvivalBusulfanLeukemiaLiver TransplantationHistocompatibility TestingHistocompatibilityTreatment OutcomeHematopoiesisAnemia, AplasticRecurrenceCord Blood Stem Cell TransplantationGraft vs Leukemia EffectRetrospective StudiesCombined Modality TherapyImmunosuppressive AgentsRemission InductionTransplantation, IsogeneicCyclophosphamideHematopoietic Stem Cell MobilizationHepatic Veno-Occlusive DiseaseLeukemia, Myeloid, AcuteKidney TransplantationAntigens, CD34Myeloablative AgonistsMice, Inbred C57BLChimerismTime FactorsBone and BonesHLA AntigensHematologic DiseasesTransplantation ImmunologyCell DifferentiationMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisGraft vs Tumor EffectSevere Combined ImmunodeficiencyLymphocyte TransfusionBone Marrow PurgingMultiple MyelomaSurvival RateGraft RejectionLymphocyte DepletionAcute DiseaseColony-Forming Units AssayCell TransplantationDisease-Free SurvivalMesenchymal Stem Cell TransplantationFlow CytometryMelphalanT-LymphocytesImmunosuppressionCell LineageLymphoma, Non-HodgkinBone Marrow DiseasesLeukemia, MyeloidRadiation ChimeraGranulocyte Colony-Stimulating FactorSiblingsCytomegalovirus InfectionsHeart TransplantationAntineoplastic Combined Chemotherapy ProtocolsVidarabineFollow-Up StudiesAntilymphocyte SerumUnrelated DonorsLung TransplantationCells, CulturedOrgan TransplantationSalvage TherapyFetal BloodCell SeparationStem Cell NicheCytarabineCyclosporineLeukocyte TransfusionOpportunistic InfectionsPrognosisEmbryonic Stem CellsAdult Stem CellsInfectionTransplantationImmunocompromised Host